Influence of gold marker for magnetic resonance imaging during prostate radiotherapy

Open access


Gold markers (GM) are increasingly used for CT and MRI registration during in intensity-modulated radiation therapy for prostate cancer. Additionally, diffusion-weighted imaging has been adopted to measure the effects of radiotherapy for prostate cancer, similar to tests of blood prostate-specific antigen levels. As diffusion-weighted imaging (DWI) is often affected by a magnetic component, we evaluated the influence of GM on the Diffusion weighted images in three cases. We found that the size range of signal void of GM in MRI was 2–5 mm. We conclude that a GM would not affect the quality of DWI in daily practice.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • [1] Yamaguchi H Hori M Suzuki O et al. Clinical Significance of the Apparent Diffusion Coefficient Ratio in Prostate Cancer Treatment with Intensity-modulated Radiotherapy Anticancer Res. 2016;36(12):6551-6556.

  • [2] Qi WX Zhang Q Li P et al. The predictive role of ADC values in prostate cancer patients treated with carbon-ion radiotherapy: initial clinical experience at Shanghai Proton and Heavy Ion Center (SPHIC). J Cancer Res Clin Oncol. 2016;142(6):1361-1367.

  • [3] Casares-Magaz O van der Heide UA Rørvik J et al. A tumour control probability model for radiotherapy of prostate cancer using magnetic resonance imaging-based apparent diffusion coefficient maps. Radiother Oncol. 2016;119(1):111-116.

  • [4] Iannelli G Caivano R Rago L et al. Diffusion-weighted magnetic resonance imaging in patients with prostate cancer treated with radiotherapy. Tumori. 2016;102(1):71-76.

  • [5] Decker G Mürtz P Gieseke J et al. Intensity-modulated radiotherapy of the prostate: dynamic ADC monitoring by DWI at 3.0 T. Radiother Oncol. 2014;113(1):115-120.

  • [6] Morgan VA Riches SF Giles S et al. Diffusion-weighted MRI for locally recurrent prostate cancer after external beam radiotherapy. AJR Am J Roentgenol. 2012;198(3):596-602.

  • [7] Park SY Kim CK Park BK et al. Early changes in apparent diffusion coefficient from diffusion-weighted MR imaging during radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2012;83(2):749-755.

  • [8] Song I Kim CK Park BK Park W. Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T. AJR Am J Roentgenol. 2010;194(6):477-482.

Journal information
Impact Factor

CiteScore 2018: 0.38

ICV 2017 = 103.49

SCImago Journal Rank (SJR) 2018: 0.132
Source Normalized Impact per Paper (SNIP) 2018: 0.303

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 208 165 7
PDF Downloads 118 88 4